Amalgamated Financial’s Caribou Biosciences CRBU Stock Holding History

Amalgamated Financial’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$45K	Buy	+4,851	New	+$51.1K	﹤0.01%	2479

Other funds holding CRBU

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

RCMU

Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return

Amalgamated Financial's CRBU Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Caribou Biosciences (CRBU) in Q1 2022: 4,851 shares worth $45K. The stake represents ﹤0.01% of the portfolio and ranks #2479 among its holdings.

104 funds tracked by Wall St. Rank hold CRBU as of Q1 2022.

Amalgamated Financial held 4,851 shares of Caribou Biosciences worth $45K as of Q1 2022.
Caribou Biosciences was a new Amalgamated Financial position in Q1 2022.
Caribou Biosciences made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2479 holding.
104 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.